The Minister of State (Science and Technology), announced Friday investment for new research infrastructure through the Canadian Foundation for Innovation, that Canadian researchers across the country will use to advance knowledge. An amount of $6.5-million was allocated to CHU Sainte-Justine and Université de Montréal, partners on the Research Program for Rare Pediatric Diseases RaPiD, a transcanadian pipeline for the discovery, disease phenotyping and mechanism identification, as well as identification of efficient treatment approaches for pediatric rare diseases and cancers, to be conducted in collaboration with University of Ottawa, the Children’s Hospital of Eastern Ontario, Dalhousie University and University of British Columbia.

The announced federal funding is pivotal in consolidating genomics research at CHU Sainte-Justine, which is responsible for the diagnosis and treatment of a majority of the most serious childhood diseases in Quebec. It will also help enhance the genomics and bioinformatics core facilities of Génome Québec and CHU Sainte-Justine Integrated Clinical Genomic Center in Pediatrics, and be an invaluable resource for CHU Sainte-Justine Center for Rare Genetic Disorders.


To learn more: